| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.2 | 0.007 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.007 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.007 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.096 | 0.008 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.008 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.009 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.097 | 0.009 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.15 | 0.009 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.009 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.009 |